| 書(shū)目名稱 | Clinical Benefits of Leukodepleted Blood Products | | 編輯 | Joseph Sweeney,Andrew Heaton | | 視頻video | http://file.papertrans.cn/228/227820/227820.mp4 | | 叢書(shū)名稱 | Medical Intelligence Unit | | 圖書(shū)封面 |  | | 描述 | Joseph Sweeney, Andrew Heaton he presence of allogeneic leukocytes in blood products received little T attention until the mid-1950s when these "passenger" cells were im- plicated in the etiology of febrile transfusion reactions, and early strate- gies based on centrifugation were developed to effect their removal. In recent decades and, particularly in the past five years, there has been an accumulation of literature implicating leukocytes in a wide variety of undesirable reactions to blood transfusion. White cells are the least numerous of the cellular elements in blood and ratios of white cells to platelets and white cells to red cells are ap- proximately 1:15 to 1:1000 respectively. This ratio is maintained in whole blood, but may be altered slightly in the process of component prepara- tion. Any production or processing step which intentionally decreases this ratio will result in a product which can be described as white cell depleted. It has, however, become more common to define the outcome as a residual white cell content, rather than a decrease in cellular ratios, although the latter makes more sense on theoretical grounds, since deple- tion of white cells needs to be put | | 出版日期 | Book 1995 | | 關(guān)鍵詞 | attention; blood; blood cell; cell; cells; cytokine; cytokines; heart; immunization; immunomodulation; lung; pr | | 版次 | 1 | | doi | https://doi.org/10.1007/978-3-662-26538-3 | | isbn_softcover | 978-1-57059-122-8 | | isbn_ebook | 978-3-662-26538-3 | | copyright | Springer-Verlag Berlin Heidelberg 1995 |
The information of publication is updating
|
|
|Archiver|手機(jī)版|小黑屋|
派博傳思國(guó)際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-9 22:51
發(fā)表于 2025-3-21 18:20:49
